1. Home
  2. CHEK

as 12-17-2024 4:00pm EST

$
-
.
-
-
-
$
-
.
-
-
-
-
.
-
-
%

Stocks

Health Care

Medical Electronics

Nasdaq

Check-Cap Ltd is a clinical-stage medical diagnostics company engaged in the development of an ingestible imaging capsule that utilizes low-dose X-rays for the detection and imaging of colonic polyps and colorectal cancers, or CRC. The company is developing C-Scan, the first capsule-based system for preparation-free, colorectal cancer screening. Its scanning capsule will be swallowed and propelled by natural motility through the gastrointestinal tract and excreted naturally with no need for retrieval for data collection. The operations of the company are presently located in Israel, but it currently expects to market products in the United States, Europe, Israel and Japan.

Founded: 2004 Country:
Israel
Israel
Employees: N/A City: N/A
Market Cap: 5.1M IPO Year: 2015
Target Price: N/A AVG Volume (30 days): 14.0K
Analyst Decision: N/A Number of Analysts: N/A
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: -3.00 EPS Growth: N/A
52 Week Low/High: $0.61 - $3.45 Next Earning Date: 02-14-2025
Revenue: N/A Revenue Growth: N/A
Revenue Growth (this year): N/A Revenue Growth (next year): N/A

CHEK Daily Stock ML Predictions

Share on Social Networks: